Form 4: NeuroOne Medical Technologies CEO David Rosa Disposes of Shares to Cover Tax Obligations
SEC Form 4 Filing
CEO David Rosa disposed of 19,673 shares of NeuroOne Medical Technologies to cover tax obligations related to vested restricted stock units.
Summary
- On April 21, 2024, David A Rosa, CEO and President of NeuroOne Medical Technologies Corp, disposed of 19,673 shares of common stock.
- The transaction was executed to cover tax obligations.
- Following the transaction, Rosa directly owns 1,164,836 shares of NeuroOne Medical Technologies Corp.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing related to an insider transaction. It doesn't inherently convey positive or negative sentiment.
Industry Context
This is a routine disclosure of an insider transaction. It is common for executives to sell shares to cover tax obligations related to stock-based compensation.
Stakeholder Impact
- The disposal of shares by the CEO could have a minor negative impact on shareholder sentiment, although it is a common practice to cover tax obligations.
Key Dates
| Date | Description |
|---|---|
| 04/21/2024 | Date of transaction: David Rosa disposed of 19,673 shares of common stock. |
| 04/23/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.